Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001301120-25-000039 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 29, 2025 |
| Document Date | Dec 23, 2025 |
| Document | View SEC Filing |
Transactions
3
Total Shares
12,300
Total Value
$10,906.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Dec 23, 2025 | Exercise/Conversion | 4,100 | $0.06 | $246.00 | 4,100 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Dec 23, 2025 | Sale | 4,100 | $2.60 | $10,660.00 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Dec 23, 2025 | Exercise/Conversion | 4,100 | $0.00 | $0.00 | 352,186 | Direct | โ | View Details |